Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

Ola Landgren, Ethel S. Gilbert, J. Douglas Rizzo, Gérard Socié, Peter M. Banks, Kathleen A. Sobocinski, Mary M. Horowitz, Elaine S. Jaffe, Douglas W. Kingma, Lois B. Travis, Mary E. Flowers, Paul J. Martin, H. Joachim Deeg, Rochelle E. Curtis

Research output: Contribution to journalArticlepeer-review

280 Scopus citations


We evaluated 26 901 patients who underwent allogeneic hematopoietic cell transplantation (HCT) at 271 centers worldwide to define patterns of posttransplantation lymphoproliferative disorders (PTLDs). PTLDs developed in 127 recipients, with 105 (83%) cases occurring within 1 year after transplantation. In multivariate analyses, we confirmed that PTLD risks were strongly associated (P < .001) with T-cell depletion of the donor marrow, antithymocyte globulin (ATG) use, and unrelated or HLA-mismatched grafts (URD/HLA mismatch). Significant associations were also confirmed for acute and chronic graft-versus-host disease. The increased risk associated with URD/HLA-mismatched donors (RR = 3.8) was limited to patients with T-cell depletion or ATG use (P = .004). New findings were elevated risks for age 50 years or older at transplantation (RR = 5.1; P < .001) and second transplantation (RR = 3.5; P < .001). Lower risks were found for T-cell depletion methods that remove both T and B cells (alemtuzumab and elutriation, RR = 3.1; P = .025) compared with other methods (RR = 9.4; P = .005 for difference). The cumulative incidence of PTLDs was low (0.2%) among 21 686 patients with no major risk factors, but increased to 1.1%, 3.6%, and 8.1% with 1, 2, and more than 3 major risk factors, respectively. Our findings identify subgroups of patients who underwent allogeneic HCT at elevated risk of PTLDs for whom prospective monitoring of Epstein-Barr virus activation and early treatment intervention may be particularly beneficial.

Original languageEnglish (US)
Pages (from-to)4992-5001
Number of pages10
Issue number20
StatePublished - 2009
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation'. Together they form a unique fingerprint.

Cite this